Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bertrand

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2023
Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in FranceDominique Bertrand, Mélanie Brunel, Ludivine Lebourg, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 23, 2010
[Management and follow-up of patients treated with antiretroviral prophylaxis: an evaluation of professional practices]Aude Le Divenah, Stéphane David, Mélanie Brignone, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2026
ABO-incompatible kidney transplantation: impact of apheresis on graft and patient survival in recipients with low isoagglutinin titerMarion Mangin, Juliette Lucas, Benjamin Taton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2023
A Simple Molecular Tool for the Assessment of Kidney Transplant BiopsiesTristan de Nattes, Jack Beadle, Frederic Toulza, et al.
Journal of Nephrology|June 28, 2021
Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three yearsTristan de Nattes, Arnaud François, Sophie Candon, et al.
Nephrologie & Therapeutique|March 11, 2025
Early conversion to belatacept post-transplantation: state of the art and expert opinionJohan Noble, Dany Anglicheau, Gilles Blancho, et al.
British Journal of Clinical Pharmacology|February 19, 2024
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokineticsOlivier Le Tilly, Philippe Gatault, Saida Semlali, et al.
The Analyst|January 10, 2017
Ultra-filtration of human serum for improved quantitative analysis of low molecular weight biomarkers using ATR-IR spectroscopyFranck Bonnier, Hélène Blasco, Clément Wasselet, et al.
British Journal of Clinical Pharmacology|October 29, 2020
Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric studyChristophe Passot, Rebecca Sberro-Soussan, Dominique Bertrand, et al.
Transplantation Direct|April 15, 2024
Use of a Belatacept-based Immunosuppression for Kidney Transplantation From Donors After Circulatory Death: A Paired Kidney AnalysisRita Eid, Anne Scemla, Magali Giral, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2023
Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in FranceDominique Bertrand, Mélanie Brunel, Ludivine Lebourg, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 23, 2010
[Management and follow-up of patients treated with antiretroviral prophylaxis: an evaluation of professional practices]Aude Le Divenah, Stéphane David, Mélanie Brignone, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2026
ABO-incompatible kidney transplantation: impact of apheresis on graft and patient survival in recipients with low isoagglutinin titerMarion Mangin, Juliette Lucas, Benjamin Taton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2023
A Simple Molecular Tool for the Assessment of Kidney Transplant BiopsiesTristan de Nattes, Jack Beadle, Frederic Toulza, et al.
Journal of Nephrology|June 28, 2021
Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three yearsTristan de Nattes, Arnaud François, Sophie Candon, et al.
Nephrologie & Therapeutique|March 11, 2025
Early conversion to belatacept post-transplantation: state of the art and expert opinionJohan Noble, Dany Anglicheau, Gilles Blancho, et al.
British Journal of Clinical Pharmacology|February 19, 2024
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokineticsOlivier Le Tilly, Philippe Gatault, Saida Semlali, et al.
The Analyst|January 10, 2017
Ultra-filtration of human serum for improved quantitative analysis of low molecular weight biomarkers using ATR-IR spectroscopyFranck Bonnier, Hélène Blasco, Clément Wasselet, et al.
British Journal of Clinical Pharmacology|October 29, 2020
Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric studyChristophe Passot, Rebecca Sberro-Soussan, Dominique Bertrand, et al.
Transplantation Direct|April 15, 2024
Use of a Belatacept-based Immunosuppression for Kidney Transplantation From Donors After Circulatory Death: A Paired Kidney AnalysisRita Eid, Anne Scemla, Magali Giral, et al.
Pageof 16